The ECTRIMS podcast

The ECTRIMS Podcast

1
The Expanding Role of Patient-Reported Outcomes in MS Research 20:15

5일 전20:15

나중에 재생

리스트

20:15

Patient-reported outcomes (PROs) have become a critical tool for capturing the lived experience of multiple sclerosis (MS), offering a perspective that extends beyond traditional clinical and imaging metrics. As research increasingly prioritises real-world relevance and individualised care, PROs provide valuable insights into symptoms such as fatigue, mood changes, and cognitive decline—factors that often evade objective measurement but have a profound impact on quality of life. Professor Jan Hillert of Karolinska Institute in Sweden and chair of the Swedish MS Registry joins host Brett Drummond of MStranslate to discuss how patient reported data are being integrated into clinical trial design and observational studies. They also explore current limitations to their use and highlight best practices for validation and interpretation.…

The ECTRIMS Podcast

1
Biomarkers in MS 25:48

6 weeks 전25:48

나중에 재생

리스트

25:48

Biomarkers are one of the most exciting and fast-evolving areas in multiple sclerosis research, offering promise for earlier diagnosis, accurate prognosis, and truly personalised treatment. Yet despite their potential, there is still significant debate that limits their widespread application in clinical and research settings. In this episode, host Brett Drummond is joined by two leading voices in this field, Professor Charlotte Teunissen of Amsterdam UMC in The Netherlands and Associate Professor Michael Khalil of Medical University of Graz in Austria to explore the most promising biomarker candidates and when and how they might be implemented.…

The ECTRIMS Podcast

1
BTK Inhibitors: The Tolebrutinib Trial Results 25:07

9 weeks 전25:07

나중에 재생

리스트

25:07

Over the past few years, the MS research community has been following developments in a new class of therapies called Bruton's tyrosine kinase inhibitors (BTKis). At ECTRIMS 2024, the results of two tolebrutinib trials were presented as late-breaking abstracts by Dr. Robert Fox, Neurologist at the Mellen Center for Multiple Sclerosis at Cleveland Clinic in the US, and Dr. Jiwon Oh, Neurologist at St. Michael's Hospital at the University of Toronto. The full results were recently published in The New England Journal of Medicine. In this episode, host Brett Drummond of MStranslate spoke with Drs. Oh and Fox about the outcomes and what they mean for people with MS.…

The ECTRIMS Podcast

1
The Role of Diet in Managing MS 28:46

13 weeks 전28:46

나중에 재생

리스트

28:46

What do the latest research findings tell us about the role diet can play in the management of multiple sclerosis (MS)? How should neurologists talk about diet with their patients? While people living with MS may view their food choices as a way to exert some control over the disease, the concept of an "ideal diet" remains hotly contested. Dr. Brigit de Jong, Neurologist at MS Center Amsterdam, investigates non-pharmacological interventions, including diet, that determine the clinical outcome and pathogenesis of MS. She joins host Brett Drummond of MSTranslate to discuss the latest evidence on dietary modifications and how they should be communicated and implemented by neurologists.…

The ECTRIMS Podcast

1
Autologous Haematopoietic Stem Cell Transplantation for MS 29:43

17 weeks 전29:43

나중에 재생

리스트

29:43

Autologous haematopoietic stem cell transplantation (AHSCT) has gained considerable attention in recent years as a treatment option for multiple sclerosis (MS). As long-term clinical trial data on AHSCT continues to grow, there is increasing debate about where it fits in the current MS therapeutic landscape. Dr. Joachim Burman, Neurologist and Associate Professor at Uppsala University in Sweden, and Dr. Jennifer Massey, Neurologist at St. Vincent's Hospital and a Senior Lecturer at the University of New South Wales in Australia, discuss the latest research and insights on this hot topic with host Brett Drummond of MStranslate.…

The ECTRIMS Podcast

1
How Real-World Data Is Shaping MS Treatment 27:02

22 weeks 전27:02

나중에 재생

리스트

27:02

The rise of multiple sclerosis (MS) registries worldwide has transformed MS research, providing access to vast clinical data spanning years. This development also triggers critical conversations about how best to use real-world data to answer questions over the treatment of people with MS and the potential shift towards personalised medicine. In this episode, guests Professor Tomas Kalincik, Head of the Clinical Outcomes Research (CORe) Unit at the University of Melbourne and the MS Centre at the Royal Melbourne Hospital in Australia, and Maria Pia Sormani, Professor of Biostatistics at the University of Genoa in Italy, share their expert insights on harnessing real-world data with host Brett Drummond of MStranslate.…

The ECTRIMS Podcast

1
Fatigue in Multiple Sclerosis 27:45

27 weeks 전27:45

나중에 재생

리스트

27:45

Fatigue is a common symptom of multiple sclerosis, significantly impacting the quality of life of people living with the disease. In this episode, Dr. Anne-Laure Dubessy of Hôpital Pitié-Salpêtrière in Paris and Professor Iris-Katharina Penner of the University Hospital of Bern in Switzerland join host Brett Drummond of MSTranslate to discuss the causes of MS-related fatigue, strategies for managing it, and the latest research developments in this area.…

The ECTRIMS Podcast

1
Advancing MS Knowledge through the ECTRIMS Fellowship 16:47

30 weeks 전16:47

나중에 재생

리스트

16:47

The recent ECTRIMS 2024 in Copenhagen showcased the work of young scientific investigators, including this year's ECTRIMS Fellowship recipients Oscar Ayala from Colombia and Zuhal Abasiyanik from Turkey. Every year, ECTRIMS awards fellowships across various categories to promote knowledge and expertise in the field of multiple sclerosis (MS). Oscar and Zuhal spoke with host Brett Drummond of MSTranslate about the research projects that they will be pursuing and how they believe this opportunity will impact their career. The ECTRIMS Fellowship application period for the 2025 cycle is now open. Apply before the deadline of December 1, 2024 at 23:59 CET.…

The ECTRIMS Podcast

1
Addressing Diversity in MS Research and Care 29:04

32 weeks 전29:04

나중에 재생

리스트

29:04

Nearly three million people worldwide are living with multiple sclerosis (MS), affecting individuals from diverse geographical, ethnic, racial, and socio-economic backgrounds. This diversity raises important questions about how these factors may influence the experiences and outcomes of those with MS, as well as whether research studies and clinical trials have sufficiently addressed this variability. To answer these questions and more, host Brett Drummond of MSTranslate speaks with two leading researchers in this field: Dr. Léorah Freeman, assistant professor at the Dell Medical School Department of Neurology, The University of Texas at Austin; and Dr. Lilyana Amezcua, Associate Professor of Clinical Neurology at the University of Southern California's Keck School of Medicine.…

The ECTRIMS Podcast

1
Paediatric Multiple Sclerosis 24:01

34 weeks 전24:01

나중에 재생

리스트

24:01

While paediatric onset multiple sclerosis is relatively rare, it presents unique challenges. Extensive research efforts are taking place around the world to better understand the disease mechanism of paediatric MS and the similarities and differences that exist with adult onset MS to help determine the best treatment options for children and adolescents. In this episode, host Brett Drummond of MSTranslate explores the topic with Dr. Yael Hacohen of Great Ormond Street Hospital for Children and UCL Institute of Neurology in the UK and Dr. Thaís Armangué of SJD Barcelona Children's Hospital in Spain.…

The ECTRIMS Podcast

1
MS Prodrome: Implications and Future Research Directions 19:59

37 weeks 전19:59

나중에 재생

리스트

19:59

If you talk to someone living with MS about their journey, one of the first things they will tell you is that they knew something was wrong long before they received their diagnosis. While this anecdotal evidence has been commonly discussed, it was only relatively recently that the research world has started to investigate this concept. Through this work, the idea of an MS prodrome has been studied, with potential implications for early diagnosis and treatment. Host Brett Drummond of MSTranslate speaks with Prof. Helen Tremlett of the University of British Columbia, a leading expert in recognising and investigating the MS prodrome.…

The ECTRIMS Podcast

1
Episode 37: Future MS Therapeutics 36:00

39 weeks 전36:00

나중에 재생

리스트

36:00

Significant progress has been made in multiple sclerosis (MS) treatments over the past 20 years. What does the next 20 years hold for MS therapies? What novel targets are being investigated? What clinical trials are in the pipeline and when can we expect new medications in the market? Host Brett Drummond of MS Translate explores these questions and more with Prof. Heinz Wiendl of University of Freiburg and Prof. Ludwig Kappos of University Hospital Basel.…

The ECTRIMS Podcast

1
MS Nurses at ECTRIMS 2024 26:14

41 weeks 전26:14

나중에 재생

리스트

26:14

Nurses play a specialised and unique role in the journey of people living with multiple sclerosis (MS). At ECTRIMS 2024, MS nurses showcased their experiences and insights into how to effectively support patients. In this episode, host Brett Drummond of MSTranslate talks with veteran MS nurses K-J Lazarus of Austin Health in Australia and Fiona d'Young of the Auckland Hospital in New Zealand.…

The ECTRIMS Podcast

1
Patient Community Day Highlights of ECTRIMS 2024: Part II 17:27

41 weeks 전17:27

나중에 재생

리스트

17:27

The Patient Community Day of ECTRIMS 2024 brought together people living with multiple sclerosis (MS), medical professionals, researchers, and advocates in two interactive sessions. They explored the forefront of MS research and treatment, focusing on groundbreaking topics like remyelination and myelin repair. They disussed promising new therapies that could revolutionise patient care, along with practical lifestyle changes and effective symptom management strategies. In Part II of our Patient Community Day episode, host Brett Drummond of MSTranslate talks to Sumaira Ahmed and Trevis Gleason, who are living with NMOSD and MS, respectively, about their experience attending the event.…

The ECTRIMS Podcast

1
Patient Community Day Highlights of ECTRIMS 2024: Part I 16:08

42 weeks 전16:08

나중에 재생

리스트

16:08

The Patient Community Day of ECTRIMS 2024 brought together people living with multiple sclerosis (MS), medical professionals, researchers, and advocates in two interactive sessions. They explored the forefront of MS research and treatment, focusing on groundbreaking topics like remyelination and myelin repair. They disussed promising new therapies that could revolutionise patient care, along with practical lifestyle changes and effective symptom management strategies. In Part 1 of our Patient Community Day episode, Elisabeth Kasilingam, Chief Executive Officer of the European Multiple Sclerosis Platform (EMSP) and Vice President of the European Patients’ Forum, talks with host Brett Drummond of MSTranslate about bridging the gap between patients, clinicians, and the scientific community.…

The ECTRIMS Podcast

1
Day 3 Highlights of ECTRIMS 2024 21:23

43 weeks 전21:23

나중에 재생

리스트

21:23

Former ECTRIMS President and MS Journal Editor-in-Chief Alan Thompson and host Brett Drummond wrap up the last day of ECTRIMS 2024 with their final thoughts and insights.

The ECTRIMS Podcast

1
Day 2 Highlights of ECTRIMS 2024 23:29

44 weeks 전23:29

나중에 재생

리스트

23:29

Anne Helme, Head of Research at MSIF, and host Brett Drummond discuss the key takeaways unveiled on the second day of ECTRIMS 2024 in Copenhagen, as well as the value of global collaboration.

The ECTRIMS Podcast

1
Day 1 Highlights of ECTRIMS 2024 19:47

44 weeks 전19:47

나중에 재생

리스트

19:47

ECTRIMS Vice President Bruno Stankoff highlights the most relevant insights from day one of ECTRIMS 2024 in Copenhagen, and provides a glimpse of what to expect from the ECTRIMS society in the coming year.

The ECTRIMS Podcast

1
Pre-Day Highlights of ECTRIMS 2024 17:07

44 weeks 전17:07

나중에 재생

리스트

17:07

Listen to Romain Marignier from CHU de Lyon and host Brett Drummond discuss highlights of ECTRIMS' new Pre-Day on NMOSD, MOGAD, and other rare neurological conditions.

The ECTRIMS Podcast

1
Episode 35: NMOSD and MOGAD Part II 26:08

45 weeks 전26:08

나중에 재생

리스트

26:08

Misdiagnosing multiple sclerosis (MS) is not uncommon. Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disorder (MOGAD) can have clinical manifestations similar to MS. In this two-part episode, host Brett Drummond of MSTranslate speaks with Prof. Sara Mariotto of the University of Verona in Italy and Prof. Kazuo Fujihara of Fukushima Medical University in Japan about the latest research on the pathogenesis of these diseases, diagnostic criteria, potential treatment approaches, and any learnings that may be translated to MS.…

The ECTRIMS Podcast

1
Episode 35: NMOSD and MOGAD Part I 20:35

45 weeks 전20:35

나중에 재생

리스트

20:35

The ECTRIMS Podcast

1
ECTRIMS-EAN Vaccination Consensus Statement (eanCast) 33:05

46 weeks 전33:05

나중에 재생

리스트

33:05

The following episode has been produced by the European Academy of Neurology (EAN) in collaboration with the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), and has been published on both the EAN and ECTRIMS Podcast channels to ensure our joint communities have access to it. In this episode of eanCast: Weekly Neurology, host Melinda Magyari is joined by ECTRIMS Podcast host Brett Drummond to talk about the ECTRIMS-EAN Vaccination Consensus Statement with lead author Susana Otero of the Department of Preventive Medicine and Epidemiology, Vall d'Hebron Barcelona Hospital, Barcelona, Spain and the Multiple Sclerosis Centre of Catalonia (Cemcat). Read the full article here .…

The ECTRIMS Podcast

1
Environmental, Genetic, and Epigenetic Risk Factors in MS 27:11

49 weeks 전27:11

나중에 재생

리스트

27:11

Multiple sclerosis (MS) is a complex and multifaceted neurological disorder. While MS has a genetic component, it is not a classic genetic disease. For this reason, a large amount of research has been done to identify environmental factors that may also be involved. In this episode, host Brett Drummond of MSTranslate talks with Emmanuelle Waubant, Professor of Neurology and Paediatrics at the University of California, San Francisco, about the latest findings on the role that environmental, genetic, and epigenetic risk factors play in MS.…

The ECTRIMS Podcast

1
Myelin plasticity and repair 40:08

52 weeks 전40:08

나중에 재생

리스트

40:08

The next major step forward in the management of MS involves finding treatments that can repair damaged myelin. If successful, it would offer the potential to start to reverse some of the symptoms experienced by people living with MS. Bruno Stankoff, a neurologist of the Pitié-Salpêtrière Hospital in Paris and vice president of ECTRIMS, and Gianvito Martino, scientific director of the San Raffaele Scientific Institute in Milan, discuss this important MS research area with host Brett Drummond of MSTranslate.…

The ECTRIMS Podcast

1
Lifestyle Modifications in MS 30:01

1 year 전30:01

나중에 재생

리스트

30:01

People living with MS want to be able to improve their quality of life and take control of a disease that is often filled with uncertainty. In this space, no topic has generated more interest or discussion than lifestyle modifications such as diet and exercise. What is the current evidence on how effective they can be at helping manage the disease? Robert Motl, professor of kinesiology and nutrition, and rehabilitation sciences at University of Illinois-Chicago, and Kathryn Fitzgerald, assistant professor of neurology at Johns Hopkins University, join host Brett Drummond of MStranslate.…

The ECTRIMS Podcast

1
The Impact of Ageing on MS 28:52

1 year 전28:52

나중에 재생

리스트

28:52

While multiple sclerosis (MS) has been traditionally described as a disease of young adults, the significant improvements in treatments over the past few decades has meant that researchers and clinicians are now increasingly handling questions related to the impact of ageing. In this episode, host Brett Drummond of MSTranslate talks with Anneke Van Der Walt, Director of MS and Neuroimmunology and Neuro-ophthalmology at Alfred Health in Melbourne, Australia and lead of the MS and Neuro-ophthalmology Research Group at the School of Translational Medicine, Monash University; and Professor Frederik Barkhof, Chair of Neuroradiology, Brain Repair & Rehabilitation at University College London's Queen Square Institute of Neurology and Professor in Neuroradiology at the Department of Radiology & Nuclear Medicine at VUmc in Amsterdam, on the key takeaways from a recent international workshop on ageing.…

The ECTRIMS Podcast

1
Artificial Intelligence in MS Research 24:31

1 year 전24:31

나중에 재생

리스트

24:31

Artificial intelligence (AI) can be a powerful tool to help enhance our understanding of MS disease processes, improve our diagnostic accuracy, better predict disease course, and identify optimal treatments. How is AI being used in MS research currently and what may it be able to do in the future? Host Alan Thompson, Editor in Chief of MS Journal, talks with Arman Eshaghi of the Queen Square Institute of Neurology, University College London, and Daniel Ontaneda of the Cleveland Clinic Neurological Institute’s Mellen Center for Multiple Sclerosis in the United States.…

The ECTRIMS Podcast

1
Prioritising Women's Health Topics in MS Research 29:19

1 year 전29:19

나중에 재생

리스트

29:19

In a landscape where funding is increasingly difficult to obtain, the importance of conducting research that has the greatest impact has never been more important. In the case of women with MS, a large-scale scoping review,* conducted on behalf of the International Advisory Committee on Clinical Trials in MS, sheds light on the research gaps related to female health. ln this episode, host Brett Drummond of MSTranslate talks with two of its authors -- Lindsay Ross, an assistant professor at the Cleveland Clinic Lerner College of Medicine, and Ruth Ann Marrie, professor of medicine and community health sciences at the University of Manitoba in Canada. *Ross, L., Finlayson, M., Amato, M. P., Cohen, J. A., Hellwig, K., Tintore, M., Vukusic, S., Salter, A., & Marrie, R. A. (2024). Priority setting: women's health topics in multiple sclerosis. Frontiers in neurology, 15, 1355817. https://doi.org/10.3389/fneur.2024.1355817…

The ECTRIMS Podcast

1
Spotlight on Young MS Researchers 22:30

1 year 전22:30

나중에 재생

리스트

22:30

The ECTRIMS Congress offers a valuable opportunity for young researchers to gain experience and exposure. Joonas Lehikoinen from Helsinki University Hospital and the University of Helsinki Neurocenter, along with Ahmed Abdelhak from the University of California, San Francisco, received poster abstract prizes at MSMilan2023. Host Brett Drummond from MSTranslate talks with them about their research, experiences, and advice for young researchers preparing abstracts for ECTRIMS2024.…

The ECTRIMS Podcast

1
MS in the Black Community 34:52

1 year 전34:52

나중에 재생

리스트

34:52

With the growing push towards taking a more personalised approach to the treatment and management of multiple sclerosis, it is important to understand the unique issues – both socially and clinically – that may arise among people of different ethnicities. In this episode, Natalie Bursari of The Nerve of My Multiple Sclerosis in the UK and Mitzi Joi Williams of Joi Life Wellness Multiple Sclerosis Center in the US discuss the issues faced by Black people living with MS, with host Brett Drummond of MStranslate.…

Amazon eGift Card - Bright Balloons (Animated)

Bounty Paper Towels Quick Size, White, 16 Family Rolls = 40 Regular Rolls (Packaging May Vary)

Premier Protein Shake, Chocolate, 30g Protein 1g Sugar 24 Vitamins Minerals Nutrients to Support Immune Health, 11.5 fl oz (Pack of 12)

들어볼 가치가 있는 팟캐스트